Prestige Consumer Healthcare

PBH · NYSE

$49.36−$0.35 (−0.70%)TodayMarket closed ·
Prev close $49.71

Latest news

  • Press releaseGlobe Newswire

    Prestige Consumer Healthcare to Release Fiscal 2027 Second Quarter Earnings Results

  • News

    Transcript: Prestige Consumer Q1 2027 Earnings Conference Call

  • Press releasePRNewswire

    More Than Half of U.S. Women Have Avoided Talking About an Intimate Wellness Concern Because They Felt Embarrassed or Uncomfortable, New Summer's Eve® Survey Finds

  • Press releasePRNewswire

    Football Stress May Be Following Fans to Bed, According to the Inaugural DenTek® Football Stress Test

  • News

    Prestige Consumer Q1 Adj. EPS $0.98 Beats $0.88 Estimate, Sales $265.700M Beat $249.681M Estimate

  • Press releaseGlobe Newswire

    Prestige Consumer Healthcare Inc. Reports Fiscal 2027 First Quarter Results

  • Press releaseGlobe Newswire

    Prestige Consumer Healthcare Inc. Completes Acquisition of LaCorium Health, Prices $400 Million Senior Notes Offering, and Announces First Quarter Fiscal 2027 Earnings Results Date

  • Press releaseGlobe Newswire

    Prestige Consumer Healthcare Inc. Announces Offering of $400 Million Senior Notes

  • Press releasePRNewswire

    Prestige Consumer Healthcare Inc. (PBH) Clear Eyes® and Pillar5 Problems Drive Stock Lower, HBSS Investigating

  • Press releaseGlobe Newswire

    Prestige Consumer Healthcare Inc. (PBH) Clear Eyes® and Pillar5 Problems Drive Stock Lower, Hagens Berman Investigating

  • Press releasePRNewswire

    PBH Investors Have Opportunity to Join Prestige Consumer Healthcare Inc. Fraud Investigation with the Schall Law Firm

  • Press releasePRNewswire

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Prestige Consumer Healthcare Inc. - PBH

  • Press releaseGlobe Newswire

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Prestige Consumer Healthcare Inc. - PBH

  • Press releaseGlobe Newswire

    PBH Investors Have Opportunity to Join Prestige Consumer Healthcare Inc. Fraud Investigation with the Schall Law Firm

  • Press releaseBusiness Wire

    Securities Fraud Investigation Into Prestige Consumer Healthcare (PBH) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

  • Press releaseBusiness Wire

    Prestige Consumer Healthcare (PBH) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

  • Press releaseBusiness Wire

    Securities Fraud Investigation Into Prestige Consumer Healthcare (PBH) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

  • Press releasePRNewswire

    Prestige Consumer Healthcare, Inc. (PBH) Securities Fraud Investigation - Levi & Korsinsky

  • Press releasePRNewswire

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Prestige Consumer Healthcare Inc. - PBH

  • Press releaseBusiness Wire

    PBH Investor Alert: Levi & Korsinsky Investigates Prestige Consumer Healthcare (PBH) for Potential Securities Fraud

  • Press releaseGlobe Newswire

    INVESTOR ALERT: Investigation of Prestige Consumer Healthcare Inc. (PBH) announced by Holzer & Holzer, LLC

  • Press releaseBusiness Wire

    Securities Fraud Investigation Into Prestige Consumer Healthcare (PBH) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

  • Press releaseBusiness Wire

    Prestige Consumer Healthcare (PBH) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

  • Press releaseBusiness Wire

    Securities Fraud Investigation Into Prestige Consumer Healthcare (PBH) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

  • News

    Transcript: Prestige Consumer Q4 2026 Earnings Conference Call

  • Press releaseGlobe Newswire

    Prestige Consumer Healthcare Inc. Reports Fiscal 2026 Results, Announces Acquisition of LaCorium Health

  • NewsNabaparna Bhattacharya

    Prestige Bets $1 Billion On World's Most Iconic Nasal Strip

  • Press releaseGlobe Newswire

    Prestige Consumer Healthcare Announces Agreement to Acquire Breathe Right®, the Leader in Nasal Strips

  • Press releasePRNewswire

    Accessible Health Platforms Gain Scale Across $6T Health and Wellness Market

  • News

    Earnings Scheduled For February 5, 2026

  • Press releaseGlobe Newswire

    Prestige Consumer Healthcare Inc. Reports Third Quarter and Year-to-Date Fiscal 2026 Results

  • News

    Prestige Consumer's Earnings: A Preview

  • News

    Earnings Scheduled For November 6, 2025

  • News

    Earnings Scheduled For May 8, 2025

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.